CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Evanston, Illinois, United States and 19 other locations
immediate and sustained improvement in walking dysfunction, symptoms, and health-related quality of life (HRQOL) among African-Americans with MS...
Chicago, Illinois, United States
of Ublituximab (Briumvi) twice annually in participants with early MS over a treatment observation period of \~12 months.2. study the pre- a...
Phase 4
Chicago, Illinois, United States
This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS...
Phase 4
Winfield, Illinois, United States and 21 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Chicago, Illinois, United States and 241 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Merrillville, Indiana, United States and 249 other locations
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...
Phase 3
Northbrook, Illinois, United States of America and 352 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...
Phase 3
Chicago, Illinois, United States and 299 other locations
Clinical trials
Research sites
Resources
Legal